Perineural invasion as a prognostic factor in patients with stage I-III rectal cancer - 5-year follow up.

Abstract:

BACKGROUND:Rectal cancer (RC) is one of the most common diagnosed cancers, and one of the major causes of cancer-related death nowadays. Majority of the current guidelines rely on TNM classification regarding therapy regiments, however recent studies suggest that additional histopathological findings could affect the disease course. AIM:To determine whether perineural invasion alone or in combination with lymphovascular invasion have an effect on 5-years overall survival (OS) of RC patients. METHODS:A prospective study included newly diagnosed stage I-III RC patients treated and followed at the Digestive Surgery Clinic, Clinical Center of Serbia, between the years of 2014-2016. All patients had their diagnosis histologically confirmed in accordance with both TMN and Dukes classification. In addition, the patient's demographics, surgical details, postoperative pathological details, differentiation degree and their correlation with OS was investigated. RESULTS:Of 245 included patients with stage I-III RC, lymphovascular invasion (LVI) was identified in 92 patients (38%), whereas perineural invasion (PNI) was present in 46 patients (19%). Using Kaplan-Meier analysis for overall survival rate, we have found that both LVI and PNI were associated with lower survival rates (P < 0.01). Moreover when Cox multiple regression model was used, LVI, PNI, older age, male gender were predictors of poor prognosis (HR = 5.49; 95%CI: 2.889-10.429; P < 0.05). CONCLUSION:LVI and PNI were significant factors predicting worse prognosis in early and intermediate RC patients, hence more aggressive therapy should be reserved for these patients after curative resection.

authors

Stojkovic Lalosevic M,Milovanovic T,Micev M,Stojkovic M,Dragasevic S,Stulic M,Rankovic I,Dugalic V,Krivokapic Z,Pavlovic Markovic A

doi

10.4251/wjgo.v12.i5.592

subject

Has Abstract

pub_date

2020-05-15 00:00:00

pages

592-600

issue

5

issn

1948-5204

journal_volume

12

pub_type

杂志文章
  • Severe colitis associated with docetaxel use: A report of four cases.

    abstract::Diarrhea is a common side effect of chemotherapy. Pseudomembranous colitis is a well known complication of antibiotic treatment that can also be observed, albeit rarely, with certain chemotherapeutic agents. We present four cases of severe colitis in patients undergoing treatment with taxane-based chemotherapy for pan...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v2.i10.390

    authors: Carrion AF,Hosein PJ,Cooper EM,Lopes G,Pelaez L,Rocha-Lima CM

    更新日期:2010-10-15 00:00:00

  • Colorectal carcinogenesis: Insights into the cell death and signal transduction pathways: A review.

    abstract::Colorectal carcinogenesis (CRC) imposes a major health burden in developing countries. It is the third major cause of cancer deaths. Despite several treatment strategies, novel drugs are warranted to reduce the severity of this disease. Adenomatous polyps in the colon are the major culprits in CRC and found in 45% of ...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v10.i9.244

    authors: Pandurangan AK,Divya T,Kumar K,Dineshbabu V,Velavan B,Sudhandiran G

    更新日期:2018-09-15 00:00:00

  • Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib.

    abstract:BACKGROUND:Regorafenib is an oral small-molecule multikinase inhibitor approved in third or later line of treatment for patients with metastatic colorectal cancer (mCRC). Regorafenib has shown significant benefits in overall survival and progression free survival in two phase III trials compared to placebo in patients ...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v12.i3.301

    authors: Ricci V,Granetto C,Falletta A,Paccagnella M,Abbona A,Fea E,Fabozzi T,Lo Nigro C,Merlano MC

    更新日期:2020-03-15 00:00:00

  • Markers of bile duct tumors.

    abstract::Biliary tract carcinomas are relatively rare, representing less than 1% of cancers. However, their incidence has increased in Japan and in industrialized countries like the USA. Biliary tract tumors have a poor prognosis and a high mortality rate because they are usually detected late in the course of the disease; the...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v3.i4.49

    authors: Malaguarnera G,Giordano M,Paladina I,Rando A,Uccello M,Basile F,Biondi A,Carnazzo S,Alessandria I,Mazzarino C

    更新日期:2011-04-15 00:00:00

  • Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids.

    abstract::5-flurouracil (5-FU)-based chemotherapy is the main pharmacological therapy for advanced colorectal cancer (CRC). Despite significant progress in the treatment of CRC during the last decades, 5-FU drug resistance remains the most important cause of failure in CRC therapy. Resistance to 5-FU is a complex and multistep ...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v12.i9.942

    authors: Sabeti Aghabozorgi A,Moradi Sarabi M,Jafarzadeh-Esfehani R,Koochakkhani S,Hassanzadeh M,Kavousipour S,Eftekhar E

    更新日期:2020-09-15 00:00:00

  • LncRNA C9orf139 can regulate the growth of pancreatic cancer by mediating the miR-663a/Sox12 axis.

    abstract:BACKGROUND:Recent studies have proved the important role of many oncogenic long non-coding RNAs (lncRNAs) in the progression of pancreatic cancer, but little is known about the mechanisms of tumor suppression in pancreatic cancer. AIM:To evaluate the function of tumor suppressor lncRNA C9orf139 in pancreatic cancer pr...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v12.i11.1272

    authors: Ge JN,Yan D,Ge CL,Wei MJ

    更新日期:2020-11-15 00:00:00

  • Emerging molecular targets and therapy for cholangiocarcinoma.

    abstract::Cholangiocarcinoma (CCA) is a rare cancer arising from the biliary tree with a poor prognosis and limited therapeutic options. Recent large scale molecular characterisation studies have identified recurrent genetic alterations in CCA which may be amenable to therapeutic targeting. In this review we explore the genomic...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v9.i7.268

    authors: Kayhanian H,Smyth EC,Braconi C

    更新日期:2017-07-15 00:00:00

  • Endoscopic electronic record: A new approach for improving management of colorectal cancer prevention.

    abstract::Digestive endoscopy is currently the main diagnostic procedure for investigation of the digestive tract when a digestive disease is suspected. The use of computers and electronic medical records for the management of endoscopic data are an important key to improving endoscopy unit efficiency and productivity. This tec...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v4.i4.76

    authors: Maserat E,Safdari R,Maserat E,Zali MR

    更新日期:2012-04-15 00:00:00

  • Isolated pancreatic metastasis of hepatocellular carcinoma after curative resection.

    abstract::Hepatocellular carcinoma (HCC) is a highly malignant tumor and extrahepatic metastasis is not rare. The most common organ of HCC metastasis is lung, followed by bone and adrenal gland. To the best of our knowledge, isolated pancreatic metastasis of HCC that developed after curative resection has not been described pre...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v2.i4.209

    authors: Woo SM,Park JW,Han SS,Choi JI,Lee WJ,Park SJ,Hong EK,Kim CM

    更新日期:2010-04-15 00:00:00

  • Apoptotic pathways as a therapeutic target for colorectal cancer treatment.

    abstract::Colorectal cancer is the second leading cause of death from cancer among adults. The disease begins as a benign adenomatous polyp, which develops into an advanced adenoma with high-grade dysplasia and then progresses to an invasive cancer. Appropriate apoptotic signaling is fundamentally important to preserve a health...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v8.i8.583

    authors: Abraha AM,Ketema EB

    更新日期:2016-08-15 00:00:00

  • Tumor stem cell, or its niche, which plays a primary role in tumorigenesis?

    abstract::Cancer research over the past decades has focused on neoplastic cells, or a fraction of them, i.e. tumor stem cells, as the ultimate causes of tumorigenesis. However, during recent years, scientists have come to realize that tumorigenesis is not a solo act of neoplastic cells, but rather a cooperative process in which...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v2.i5.218

    authors: Zhu J,Ding J,Ding F

    更新日期:2010-05-15 00:00:00

  • Targeted agents for second-line treatment of advanced hepatocellular carcinoma.

    abstract::Over the past ten years, sorafenib, a multikinase inhibitor, has been the standard of care for patients with unresectable hepatocellular carcinoma (HCC) and well-preserved liver function. Recently, lenvatinib, a different multikinase inhibitor, was shown to be non-inferior to sorafenib, in terms of survival, while all...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v11.i10.788

    authors: Personeni N,Pressiani T,Bozzarelli S,Rimassa L

    更新日期:2019-10-15 00:00:00

  • Gastric metastasis from primary lung adenocarcinoma mimicking primary gastric cancer.

    abstract::Gastric metastases from lung adenocarcinoma are rare. Because gastric metastasis grossly resembles advanced gastric cancer, it is difficult to diagnose gastric metastasis especially when the histology of the primary lung cancer is adenocarcinoma. We describe a case of gastric metastasis from primary lung adenocarcinom...

    journal_title:World journal of gastrointestinal oncology

    pub_type:

    doi:10.4251/wjgo.v7.i3.12

    authors: Kim MJ,Hong JH,Park ES,Byun JH

    更新日期:2015-03-15 00:00:00

  • Pathology handling of pancreatoduodenectomy specimens: Approaches and controversies.

    abstract::Pancreatic cancer, with a 5% 5-year survival rate, is the fourth leading cause of cancer death in Western countries. Unfortunately, only 20% of all patients benefit from surgical treatment. The need to prolong survival has prompted pathologists to develop improved protocols to evaluate pancreatic specimens and their s...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v6.i9.351

    authors: Gómez-Mateo Mdel C,Sabater-Ortí L,Ferrández-Izquierdo A

    更新日期:2014-09-15 00:00:00

  • Ileal inflammatory fibroid polyp causing chronic ileocolic intussusception and mimicking cecal carcinoma.

    abstract::Inflammatory fibroid polyp (IFP) is a rare, idiopathic pseudotumorous lesion of the gastrointestinal tract. While mostly reported as solitary gastric lesions, multiple cases of small bowel IFPs are also reported. It is a documented cause of intussusception in adults. In the case reports of ileal inflammatory fibroid p...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v1.i1.89

    authors: Gara N,Falzarano JS,Limm WM,Namiki TS,Tom LK

    更新日期:2009-10-15 00:00:00

  • Current strategies for malignant pedunculated colorectal polyps.

    abstract::Despite significant advances in imaging techniques, the incidence of colorectal cancer has been increasing in recent years, with many cases still being diagnosed in advanced stages. Early detection and accurate staging remain the main factors that lead to a decrease in the cost and invasiveness of the curative techniq...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v10.i12.465

    authors: Ciocalteu A,Gheonea DI,Saftoiu A,Streba L,Dragoescu NA,Tenea-Cojan TS

    更新日期:2018-12-15 00:00:00

  • Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review.

    abstract::Most patients treated with curative intent for colorectal cancer (CRC) are included in a follow-up program involving periodic evaluations. The survival benefits of a follow-up program are well delineated, and previous meta-analyses have suggested an overall survival improvement of 5%-10% by intensive follow-up. Howeve...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v6.i5.104

    authors: Augestad KM,Rose J,Crawshaw B,Cooper G,Delaney C

    更新日期:2014-05-15 00:00:00

  • Bayesian adjustment for over-estimation and under-estimation of gastric cancer incidence across Iranian provinces.

    abstract:AIM:To correct the misclassification in registered gastric cancer incidence across Iranian provinces in cancer registry data. METHODS:Gastric cancer data is extracted from Iranian annual of national cancer registration report 2008. A Bayesian method with beta prior is implemented to estimate the rate of misclassificat...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v9.i2.87

    authors: Hajizadeh N,Pourhoseingholi MA,Baghestani AR,Abadi A,Zali MR

    更新日期:2017-02-15 00:00:00

  • Aberrant promoter methylation of p16 in colorectal adenocarcinoma in North Indian patients.

    abstract:AIM:To investigate p16 gene methylation and its expression in 30 patients with sporadic colorectal adenocarcinoma in a North Indian population. METHODS:Methylation specific polymerase chain reaction was used to detect p16 gene methylation and immunohistochemistry was used to study the p16 expression in 30 sporadic col...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v2.i7.295

    authors: Malhotra P,Kochhar R,Vaiphei K,Wig JD,Mahmood S

    更新日期:2010-07-15 00:00:00

  • Gastric cancer: The times they are a-changin'.

    abstract::Gastric cancer is the third leading cause of cancer death worldwide. Even though during these last decades gastric cancer incidence decreased in Western countries, it remains endemic and with a high incidence in Eastern countries. The survival in advanced and metastatic stage of gastric cancer is still very poor. Rece...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v7.i11.303

    authors: Satolli MA,Buffoni L,Spadi R,Roato I

    更新日期:2015-11-15 00:00:00

  • Precision medicine for gastrointestinal cancer: Recent progress and future perspective.

    abstract::Gastrointestinal (GI) cancer has a high tumor incidence and mortality rate worldwide. Despite significant improvements in radiotherapy, chemotherapy, and targeted therapy for GI cancer over the last decade, GI cancer is characterized by high recurrence rates and a dismal prognosis. There is an urgent need for new diag...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v12.i1.1

    authors: Matsuoka T,Yashiro M

    更新日期:2020-01-15 00:00:00

  • Epigenetic field defects in progression to cancer.

    abstract::A field defect is a field of pre-malignant tissue in which a new cancer is likely to arise. Field defects often appear to be histologically normal under the microscope. Recent research indicates that cells within a field defect characteristically have an increased frequency of epigenetic alterations and these may be f...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v5.i3.43

    authors: Bernstein C,Nfonsam V,Prasad AR,Bernstein H

    更新日期:2013-03-15 00:00:00

  • Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma.

    abstract::Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer mortality in the United States and the second leading cause of cancer mortality worldwide. Sorafenib is the only food and drug administration (FDA) approved as first line systemic treatment in HCC. Regorafenib and nivolumab are the only FDA approved s...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v10.i5.108

    authors: Contratto M,Wu J

    更新日期:2018-05-15 00:00:00

  • Parenchyma-sparing pancreatectomies for benign or border-line tumors of the pancreas.

    abstract::Standard pancreatic resections, such as pancreaticoduodenectomy, distal pancreatectomy, or total pancreatectomy, result in an important loss of normal pancreatic parenchyma and may cause impairment of exocrine and endocrine function. Whilst these procedures are mandatory for malignant tumors, they seem to be too exten...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v2.i6.272

    authors: Sperti C,Beltrame V,Milanetto AC,Moro M,Pedrazzoli S

    更新日期:2010-06-15 00:00:00

  • Multimodality treatment of recurrent pancreatic cancer: Mith or reality?

    abstract::Pancreatic adenocarcinoma is the fourth cause of cancer-related death in the United States. Surgery is the only potentially curative treatment, but most patients present at diagnosis with unresectable or metastatic disease. Moreover, even with an R0 resection, the majority of patients will die of disease recurrence. M...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v7.i12.375

    authors: Sperti C,Moletta L,Merigliano S

    更新日期:2015-12-15 00:00:00

  • Pneumo-CT assessing response to neoadjuvant therapy in esophageal cancer: Imaging-pathological correlation.

    abstract::Pneumo-computed tomography (PnCT) is a technique primarily developed and used to study stenotic lesions of the esophagus, gastroesophageal junction and stomach for pre-surgical planning. It helps to define both upper and lower borders of neoplasms located in the aforementioned areas. It achieves maximum lumen distensi...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v5.i12.222

    authors: Ulla M,Gentile E,Yeyati EL,Diez ML,Cavadas D,Garcia-Monaco RD,Ros PR

    更新日期:2013-12-15 00:00:00

  • Endoscopic approach to the diagnosis of pancreatic cystic tumor.

    abstract::Because of the aging of the population, prevalence of medical checkups, and advances in imaging studies, the number of pancreatic cystic lesions detected has increased. Once these lesions are detected, neoplastic cysts should be differentiated from non-neoplastic cysts. Furthermore, because of the malignant potential ...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v8.i2.159

    authors: Kawaguchi Y,Mine T

    更新日期:2016-02-15 00:00:00

  • Prognostic scoring system for synchronous brain metastasis at diagnosis of colorectal cancer: A population-based study.

    abstract:BACKGROUND:Brain metastasis (BM) from colorectal cancer (CRC) is rarely encountered clinically, and its prognosis has not been fully evaluated. AIM:To construct a scoring system and accurately predict the survival of patients with synchronous BM at diagnosis of CRC. METHODS:A retrospective study of 371 patients with ...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v12.i2.195

    authors: Quan JC,Guan X,Ma CX,Liu Z,Yang M,Zhao ZX,Sun P,Zhuang M,Wang S,Jiang Z,Wang XS

    更新日期:2020-02-15 00:00:00

  • Low rectal cancer: Sphincter preserving techniques-selection of patients, techniques and outcomes.

    abstract::Low rectal cancer is traditionally treated by abdominoperineal resection. In recent years, several new techniques for the treatment of very low rectal cancer patients aiming to preserve the gastrointestinal continuity and to improve both the oncological as well as the functional outcomes, have been emerged. Literature...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v7.i7.55

    authors: Dimitriou N,Michail O,Moris D,Griniatsos J

    更新日期:2015-07-15 00:00:00

  • Asian Americans have better outcomes of non-metastatic gastric cancer compared to other United States racial groups: A secondary analysis from a randomized study.

    abstract:BACKGROUND:It has been recognized for a long time that gastric cancer behavior and outcomes might be different between patients living in Asian countries vs patients living in Western countries. It is not clear if these differences would persist between patients of Asian ancestry and patients of other racial subgroups ...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v11.i12.1151

    authors: Abdel-Rahman O

    更新日期:2019-12-15 00:00:00